BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
8 results:

  • 1. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
    Okonechnikov K; Camgöz A; Chapman O; Wani S; Park DE; Hübner JM; Chakraborty A; Pagadala M; Bump R; Chandran S; Kraft K; Acuna-Hidalgo R; Reid D; Sikkink K; Mauermann M; Juarez EF; Jenseit A; Robinson JT; Pajtler KW; Milde T; Jäger N; Fiesel P; Morgan L; Sridhar S; Coufal NG; Levy M; Malicki D; Hobbs C; Kingsmore S; Nahas S; Snuderl M; Crawford J; Wechsler-Reya RJ; Davidson TB; Cotter J; Michaiel G; Fleischhack G; Mundlos S; Schmitt A; Carter H; Michealraj KA; Kumar SA; Taylor MD; Rich J; Buchholz F; Mesirov JP; Pfister SM; Ay F; Dixon JR; Kool M; Chavez L
    Nat Commun; 2023 Apr; 14(1):2300. PubMed ID: 37085539
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
    Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
    Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
    Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
    BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
    Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
    Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
    PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BORIS (ctcfL) is not expressed in most human breast cell lines and high grade breast carcinomas.
    Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
    PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Loss of imprinting and cancer.
    Jelinic P; Shaw P
    J Pathol; 2007 Feb; 211(3):261-8. PubMed ID: 17177177
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Conditional expression of the ctcf-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
    Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.